Naltrexone HCl: Clinically Proven to Reduce Alcohol Cravings
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.16 | $214.78 (0%) | 🛒 Add to cart |
| 60 | $6.77 | $429.55 $406.47 (5%) | 🛒 Add to cart |
| 90 | $6.64
Best per pill | $644.33 $597.16 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone Hydrochloride is a non-addictive, prescription medication approved by the FDA for the treatment of alcohol use disorder (AUD). As an opioid antagonist, it works by blocking the euphoric effects and feelings of intoxication associated with alcohol consumption, thereby helping to reduce the urge to drink. It is a cornerstone of Medication-Assisted Treatment (MAT), intended for use as part of a comprehensive treatment plan that includes counseling and psychosocial support. This pharmacotherapy is designed to support patients in maintaining abstinence and reducing heavy drinking days.
Features
- Active Pharmaceutical Ingredient: Naltrexone Hydrochloride
- Available in 50 mg oral tablets and extended-release injectable formulations
- Mechanism of Action: Competitive antagonist at mu-opioid receptors
- Bioavailability: Approximately 5-40% orally due to significant first-pass metabolism
- Half-life: Oral tablet: ~4 hours; Major metabolite (6-β-naltrexol): ~13 hours
- Excretion: Primarily renal (urine)
Benefits
- Significantly reduces the frequency and severity of alcohol cravings.
- Diminishes the rewarding and pleasurable sensations associated with drinking, aiding in extinction of drinking behaviors.
- Supports long-term abstinence and increases the number of days without alcohol consumption.
- Helps break the cycle of relapse by providing a pharmacological buffer during recovery.
- Non-habit forming and does not cause physical dependence or withdrawal upon discontinuation.
- Can be used safely in conjunction with behavioral therapies for a holistic treatment approach.
Common use
Naltrexone HCl is indicated for use in adults as part of a comprehensive management program for alcohol dependence. It is prescribed for patients who have undergone successful detoxification and have achieved initial abstinence, as its mechanism is preventive rather than remedial for acute withdrawal. It is suitable for patients aiming to achieve total abstinence as well as those pursuing a harm-reduction model to control heavy drinking. Treatment is often initiated after a thorough medical and psychiatric evaluation confirms the diagnosis of Alcohol Use Disorder.
Dosage and direction
The recommended dosage for alcohol dependence is 50 mg once daily, administered orally. Treatment can be initiated after the patient has remained opioid-free for a minimum of 7-10 days to avoid precipitating acute opioid withdrawal. The tablet can be taken with or without food. Adherence to the daily regimen is critical for efficacy. Some clinicians may utilize a targeted or “as-needed” dosing strategy, where the patient takes the medication approximately one hour prior to an anticipated situation with a high risk of drinking. The injectable extended-release formulation (380 mg) is administered intramuscularly by a healthcare professional once every four weeks.
Precautions
- A comprehensive medical history must be obtained to rule out acute hepatitis or liver failure. Liver function tests are recommended before initiation and during therapy.
- Patients should be warned that Naltrexone will block the effects of opioid analgesics. In an emergency requiring analgesia, management by non-opioid or rapid-acting opioids under direct supervision of an anesthesiologist is necessary.
- Patients must carry medical identification to alert medical personnel to the use of Naltrexone.
- Use with caution in patients with moderate to severe renal impairment.
- May cause drowsiness or dizziness. Patients should avoid driving or operating hazardous machinery until they know how the medication affects them.
- Not intended for use as a standalone treatment; must be part of a comprehensive program that includes psychosocial support.
Contraindications
- Patients receiving opioid analgesics, currently dependent on opioids, or in acute opioid withdrawal.
- Patients with a history of hypersensitivity to Naltrexone or any other components of the product.
- Patients with acute hepatitis or liver failure.
- A failed challenge with naloxone or a positive urine screen for opioids.
Possible side effect
The most common adverse reactions are largely gastrointestinal and neuropsychiatric in nature. These include:
- Nausea (~10%)
- Headache (~7%)
- Dizziness (~4%)
- Nervousness, anxiety, or insomnia (~2-10%)
- Fatigue (~4%)
- Abdominal pain/cramps (~3%) Less common but more serious side effects can include:
- Hepatotoxicity (dose-related)
- Depression and suicidal ideation
- Eosinophilic pneumonia
- Severe injection site reactions (for injectable form)
Drug interaction
- Opioid Analgesics: Naltrexone blocks the effects of opioid drugs. Attempting to overcome this blockade by taking large doses of opioids is extremely dangerous and can lead to fatal respiratory depression or coma.
- Opioid-Containing Medications: Will be rendered ineffective (e.g., antitussives, antidiarrheals).
- Thioridazine: Naltrexone may increase drowsiness caused by thioridazine.
- Drugs with Hepatotoxic Potential: Concomitant use of other medications known to cause liver injury (e.g., certain antifungals, anticonvulsants) may increase the risk of hepatotoxicity.
Missed dose
If a daily dose is missed, it should be taken as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Patients should not double the dose to make up for a missed one. Consistent daily dosing is important for maintaining receptor blockade and therapeutic efficacy.
Overdose
There is no specific antidote for Naltrexone overdose. Experience with intentional overdose is limited. In the event of a suspected overdose, medical attention should be sought immediately. Management should consist of treatment of presenting symptoms and supportive care in a monitored medical setting. Hemodialysis is not expected to be effective in enhancing elimination. In cases of co-ingestion with other substances, appropriate toxicology screening and supportive measures for those substances are required.
Storage
Store Naltrexone tablets at controlled room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, tightly closed, and out of reach of children and pets. Protect from light. Do not flush medication down the toilet or pour it into a drain. Dispose of unused medication through a medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. This medication requires a prescription and must be used under the direct supervision of a qualified healthcare professional.
Reviews
“Clinical trial data and meta-analyses consistently demonstrate Naltrexone’s efficacy. In multiple randomized, double-blind, placebo-controlled studies, Naltrexone-treated patients showed a significant reduction in relapse rates to heavy drinking compared to placebo. The number needed to treat (NNT) to prevent a return to heavy drinking is approximately 12. Patient-reported outcomes frequently cite a marked decrease in the ‘mental obsession’ with alcohol, allowing them to engage more effectively in therapy. It is considered a first-line pharmacotherapy in evidence-based guidelines from the American Psychiatric Association and the World Health Organization.”